Nantahala Capital Management, LLC 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:02 pm Unchanged | 2025-12-31 | 13G | APREA THERAPEUTICS INC APRE | Nantahala Capital Management, LLC | 411,520 4.500% | 0 (Unchanged) | Filing |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | APREA THERAPEUTICS INC APRE | Nantahala Capital Management, LLC | 411,520 7.300% | 411,520 (New Position) | Filing |